Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-01-26 | Amended | $12,650,000 | Unknown | Debt Only | SEC link | |
| 2023-11-20 | New | $2,300,000 | $2,300,000 | Debt Only | 06b | SEC link |
| 2022-01-25 | Amended | $39,151,781 | $22,149,858 | Equity Only | 06b | SEC link |
| 2021-09-09 | New | $17,001,923 | $17,001,923 | Equity Only | SEC link | |
| 2020-03-16 | New | $360,500 | $360,500 | Debt Only | 06b | SEC link |
| 2019-01-17 | New | $12,151,193 | $12,151,193 | Equity Only | 06b | SEC link |
| 2018-07-09 | Amended | $3,794,089 | $2,773,523 | Debt Only | 06b | SEC link |
| 2017-05-12 | New | $1,020,566 | $1,020,566 | Debt Only | 06b | SEC link |
| 2016-04-08 | New | $2,889,618 | $2,889,618 | Debt Only | 06b | SEC link |
| 2015-08-24 | Amended | $4,221,097 | $0 | Equity Only | 06b | SEC link |
| 2015-08-14 | Amended | $4,221,097 | $507,222 | Equity Only | 06b | SEC link |
| 2015-05-29 | New | $3,713,875 | $3,713,875 | Equity Only | 06b | SEC link |
| 2015-05-29 | New | $250,000 | $250,000 | Debt Only | 06b | SEC link |
| 2014-04-24 | New | $1,494,500 | $1,494,500 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Brent Buchine | Director |
| John Cadigan | Executive |
| John Conley | Director |
| Jason Durkin | Executive |
| J. Melville Engle | Director |
| Richard Gabriel | Director |
| Michael Huang | Director |
| Timothy Krochuk | Director |
| Tim Krochuk | Director |
| Aaron Mann | Director, Executive |
| William Mc Kee | Director |
| Max Meehan | Executive |
| Richard Russell | Director |
| Michael Samar | Executive |
| Christopher Stepanian | Director, Executive |
| Anthony Watson | Executive |
| John Reading Wilson | Director |